Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
Paolo Gelosa, Francesca Colazzo, Elena Tremoli, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-15
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction
Fuyuko Takata, Shinsuke Nakagawa, Junichi Matsumoto, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 329
MSCs-Derived Exosomes Attenuate Acute Brain Injury and Inhibit Microglial Inflammation by Reversing CysLT2R-ERK1/2 Mediated Microglia M1 Polarization
Y Zhao, Yunxiao Gan, Gewei Xu, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 1180-1190
Closed Access | Times Cited: 85
Regulation of microglia polarization after cerebral ischemia
Hao Wang, Jingjing Li, Han Zhang, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 23
The Role of Eicosanoids in Alzheimer’s Disease
Roger G. Biringer
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 14, pp. 2560-2560
Open Access | Times Cited: 58
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury
Heena Khan, Anjali Gupta, Thakur Gurjeet Singh, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 5, pp. 1240-1254
Closed Access | Times Cited: 45
Critical Roles of the Cysteine–Glutathione Axis in the Production of γ-Glutamyl Peptides in the Nervous System
Junichi Fujii, Tsukasa Osaki, Yuya Soma, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8044-8044
Open Access | Times Cited: 17
The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
Johanna Michael, Julia Marschallinger, Ludwig Aigner
Drug Discovery Today (2018) Vol. 24, Iss. 2, pp. 505-516
Open Access | Times Cited: 57
Regulation and signaling of the GPR17 receptor in oligodendroglial cells
Davide Lecca, Stefano Raffaele, Maria P. Abbracchio, et al.
Glia (2020) Vol. 68, Iss. 10, pp. 1957-1967
Closed Access | Times Cited: 46
Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug
Paolo Gelosa, Elisabetta Bonfanti, Laura Castiglioni, et al.
Pharmacological Research (2019) Vol. 142, pp. 223-236
Open Access | Times Cited: 44
Cryo‐EM structure of G‐protein‐coupled receptor GPR17 in complex with inhibitory G protein
Fang Ye, Thian‐Sze Wong, Geng Chen, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 27
Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases
Yuxi Wang, Yi Yang, Siran Zhang, et al.
Neurobiology of Aging (2019) Vol. 87, pp. 1-10
Closed Access | Times Cited: 38
Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series
Ji Soo Park, Yoo Jung Cho, Je‐Yeon Yun, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 5, pp. 2102467-2102467
Open Access | Times Cited: 21
Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Cátia F. Marques, M. Matilde Marques, Gonçalo C. Justino
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1039-1039
Open Access | Times Cited: 20
Drug repurposing for stroke intervention
Debarati Ghosh, Karan Sehgal, Babasaheb Sodnar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1974-1982
Closed Access | Times Cited: 19
The Emerging Roles of γ-Glutamyl Peptides Produced by γ-Glutamyltransferase and the Glutathione Synthesis System
Yoshitaka Ikeda, Junichi Fujii
Cells (2023) Vol. 12, Iss. 24, pp. 2831-2831
Open Access | Times Cited: 13
Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice
J. Michael, Michael S. Unger, Rodolphe Poupardin, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity
Stefano Raffaele, Nhung Nguyen, Marco Milanese, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 18, pp. 3303-3326
Open Access | Times Cited: 3
Synthesis, molecular docking, and anti-inflammatory evaluation of novel 4-(benzo[d][1,3]dioxol-5-yloxy)-N,N-2-yn-1-amine derivatives as potent cysteinyl leukotriene receptor (CysLT2) antagonists
Areej M. Jaber, Mohammed M. Al-Mahadeen, Belal O. Al-Najjar, et al.
Pharmacia (2025) Vol. 72, pp. 1-11
Open Access
Are leukotrienes really the world’s best bronchoconstrictors and at least 100 to 1000 times more potent than histamine?
Thomas Böhm, Bernd Jilma
Drug Discovery Today (2025), pp. 104349-104349
Closed Access
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
Syed Obaidur Rahman, Rakesh Kumar Singh, Salman Hussain, et al.
European Journal of Pharmacology (2018) Vol. 842, pp. 208-220
Closed Access | Times Cited: 29
G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier
Brock Pluimer, Mark Colt, Zhen Zhao
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 26
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Johan Wallin, Per Svenningsson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5606-5606
Open Access | Times Cited: 21
Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 3
Leukotriene signaling in neurodegeneration: implications for treatment strategies
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3571-3584
Closed Access | Times Cited: 3
Flavocoxid attenuates airway inflammation in ovalbumin-induced mouse asthma model
Rania R. Abdеlaziz, Mohammed Kh. ElMahdy, Ghada M. Suddеk
Chemico-Biological Interactions (2018) Vol. 292, pp. 15-23
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top